Ledger.Open graph →

SEC Form D · Amendment · filed June 11, 2019

Dance Biopharm Holdings, Inc

Offering

$59.2M

Sold

$21.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Adam K. Stern · New York, NYDirector Matt S. Jennings · San Francisco, CADirector Mike K. Kaseta · San Francisco, CAExec John S. Patton, Ph.D · San Francisco, CAExec · Director Anne S. Whitaker · San Francisco, CAExec · Director Steven S. Thornton · San Francisco, CADirector Dr. Melissa K. Rhodes · San Francisco, CAExec Ben S. Wolin · San Francisco, CADirector Kunjal Shah · New York, NYExec Sanjay F. Pichaiah · Palo Alto, CADirector David J. Prichard · Denver, COExec · Director Justin Lioi · New York, NYExec Greg P. Smith · Vancouver, British Columbia, CanadaExec · Director Edward P. Farrauto · Vancouver, British Columbia, CanadaDirector Kenneth J. Monfort · Denver, CODirector Zachary J. May · Denver, CODirector Kang M. Lee · Palo Alto, CADirector Travis Batiza · MADISON, WIDirector Alan H. Feld · Herzliya Pituach, L3Exec · Director Transcend Wealth Collective Capital, LLC · Short Hills, NJExec · Director Transcend Wealth Collective Capital OR, LLC · Short Hills, NJDirector Transcend Wealth Collective Capital Investment Management, LLC · Short Hills, NJDirector Amber Ramsey · Grand Cayman, Cayman IslandsExec Precilla Torres · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗